THE FUTURE OF MEDICAL AFFAIRS
As the healthcare landscape evolves in the US and throughout the world, life science companies must prove that their innovative products improve patient outcomes while providing benefits that are markedly different from current offerings. Market drivers today include value-based evidence and clinical outcomes, which demonstrate the link between patient outcomes and the cost of achieving … THE FUTURE OF MEDICAL AFFAIRS